Related Experiment Video
Updated: Jun 14, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Post-operative Crohn's Disease Recurrence and Infectious Complications: A Transcriptomic Analysis
Kevin A Chen1,2, Valerie Gartner1, Kimberly C Darlington1
1Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Bioinformatics Building; CB #7555, 130 Mason Farm Road, Chapel Hill, NC, 27599, USA.
This study identified overlapping gene pathways linked to Crohn's disease (CD) recurrence and post-operative complications. Downregulation of colon myogenesis is a key indicator for both adverse outcomes in CD patients.
Area of Science:
- Gastroenterology
- Molecular Biology
- Surgical Outcomes
Background:
- Crohn's disease (CD) is a chronic GI inflammatory condition with frequent surgical needs.
- Post-operative complications and recurrence significantly impact CD patient outcomes.
- Previous research examined recurrence and complications separately; this study seeks overlapping molecular pathways.
Purpose of the Study:
- To identify shared differentially expressed genes and biological pathways associated with both endoscopic recurrence and post-operative septic complications in Crohn's disease.
- To explore the molecular underpinnings of adverse outcomes following surgery in CD patients.
Main Methods:
- Analysis of gene expression data from ileum and colon tissues of 45 Crohn's disease patients.
- Utilized gene set enrichment analysis to identify relevant biological pathways.
- Employed multi-variable logistic regression to assess independent associations between gene pathways and outcomes.
Main Results:
- Upregulation of inflammatory pathways (e.g., interferon response) and epithelial mesenchymal transition in ileum tissue for both recurrence and complications.
- Downregulation of metabolic pathways (e.g., myogenesis, oxidative phosphorylation) in colon tissue for both outcomes.
- Colon myogenesis downregulation was independently associated with both endoscopic recurrence and septic complications.
Conclusions:
- Identified overlapping molecular pathways, including inflammatory and metabolic processes, linked to CD recurrence and post-operative complications.
- Suggests potential biomarkers and therapeutic targets for improving surgical outcomes in Crohn's disease.
- Highlights the need for further validation and multi-institutional studies.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

